Study on Dual-Targeted Liposomes Containing Curcumin-Copper Chelate in the Treatment of Triple-Negative Breast Cancer.

Pharmaceuticals (Basel) · 2026 · PMC12844874 · PMID 41599733

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

However, the Cu-Cur DTLPs group exhibited the lowest DLAT-positive area percentage (0.27 ± 0.08%), showing a decreasing trend compared to the saline group (0.59 ± 0.38%) ( Figure 15 ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.